tachyarrhythmia
Conditions
Interventions
Control group:Placebo
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of western medicine for tachyarrhythmia. 2. Meet the diagnostic criteria for depression and anxiety. 3. Hamilton Depression Scale (HAMD) 17 items score 7-24 points (not including 24 points) or (and) Hamilton Anxiety Scale (HAMA) 14 items score 7-21 points (not including 21 points). 4. Comply with TCM diagnostic criteria for heart palpitations (stagnation of liver and qi, syndrome of heart deficiency and timidity). 5. Aged 18-85 years. 6. There is no restriction on gender. 7. Subjects were informed and signed an informed consent form voluntarily.
Exclusion criteria
Exclusion criteria: 1. Transient tachyarrhythmia caused by tobacco, alcohol, coffee, fatigue, infection, fever, anemia, drug-induced electrolyte disturbance (such as low potassium), etc. 2. It is hereditary arrhythmia, tachyarrhythmia combined with severe angina pectoris, premature ventricular contractions with a short combined rhythm interval of = 30s), torsade de pointes type ventricular tachycardia, etc. 3. Patients who have non-drug anti-arrhythmic indications such as catheter ablation, electrical cardioversion, and willingness to operate. 4. Patients with pacemaker implantation or perioperative period. 5. Acute myocardial infarction, severe cardiac insufficiency (NYHA cardiac function class III, IV or LVEF= 2 points). 8. Patients with obvious hemodynamic disorders, syncope, hypotension, and shock. 9. Severe mental disorders or other reasons unable to cooperate. 10. Patients with severe liver, kidney, hematopoietic system and other primary diseases and dysfunctions. 11. Women who are pregnant, preparing to become pregnant or breast-feeding. 12. Patients who have participated in other clinical trials in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency and duration of tachyarrhythmia;Holter; | — |
Secondary
| Measure | Time frame |
|---|---|
| Therapeutic effect of TCM syndromes;Depression/anxiety score;Summary health status survey (SF-36) quality of life score; | — |
Countries
China
Contacts
Public ContactZhang Jingchun
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed